MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-26-0262203
Genepath Diagnostics India Private Limited - healthcare in Pune, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.93 Cr
▼ 25% YoY
Net loss · FY 2025
₹4.91 Cr
Net margin -70.8%
EBITDA · FY 2025
-₹3.05 Cr
EBITDA margin -44%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10,000
Issued & subscribed
Company age
7 yrs
Est. 2019
Employees · EPFO
52
Provident fund records
Directors on board
2
As per MCA filings
About Genepath Diagnostics India Private Limited
Data last updated:
Genepath Diagnostics India Private Limited is a private limited company based in Pune, Maharashtra, India, a subsidiary of Genepath Diagnostics Inc.. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 29 January 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2019PTC181759. Its GSTIN is 27AAHCG6623M1Z7 (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10,000. It is led by directors Nikhil Dileep Phadke and Christopher Leigh Kolenaty.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4th Floor Above Phadke Hospital 1260/B J M Road Shivajinagar, Pune, Maharashtra, India – 411004.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.93 Cr, a decline of 25% compared to the previous year. For the same year it recorded a net loss of ₹4.91 Cr (net margin -70.8%) and EBITDA of -₹3.05 Cr (EBITDA margin -44%). Revenue has grown at a compounded annual rate (CAGR) of 31% over three years and 8% over five years.
The company has about 52 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: GenePath Diagnostics.
Genepath Diagnostics India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-26-0262203). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genepathdx.com.
Company details
CIN U74999PN2019PTC181759
Registration Number 181759
Incorporation Date 29 January 2019
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 24 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Genepath Diagnostics Inc.
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-26-0262203
Recognitions & Rankings of Genepath Diagnostics India
Contact details
Genepath Diagnostics India Private Limited's registered office is in Pune, Maharashtra. Its website is genepathdx.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address4th Floor Above Phadke Hospital 1260/B J M Road Shivajinagar, Pune, Maharashtra, India – 411004
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Genepath Diagnostics India Private Limited, buy the company report.
Comprehensive company report
Genepath Diagnostics India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Genepath Diagnostics India operates one associated brand: GenePath Diagnostics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of diagnostic solutions for infectious diseases, cancers and genetic disorders | genepathdx.com |
Business activity
The main business activities of Genepath Diagnostics India are trade, professional, scientific and technical and hospital and medical care. In detail, this covers retail trading, scientific research and development and medical and dental practice, nursing, pathology, blood bank services, etc.. 3 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development | |
| Q | Hospital and Medical Care | Q2 | Medical and dental practice, Nursing, pathology, blood bank services, etc. |
To see the full business activity and turnover split of Genepath Diagnostics India Private Limited, buy the company report.
Financials of Genepath Diagnostics India Private Limited
FY 2025 filings availableGenepath Diagnostics India Private Limited reported revenue of ₹6.93 Cr (down 25% YoY) for FY 2025.
Revenue · FY 2025
₹6.93 Cr ▼ 25%
Net loss · FY 2025
₹4.91 Cr margin -70.8%
EBITDA · FY 2025
-₹3.05 Cr margin -44%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 25%
3 years · compounded
▼ 31%
5 years · compounded
▲ 8%
EBITDA CAGR growth
1 year
▲ 62%
3 years · compounded
▲ 12%
5 years · compounded
▼ 88%
Revenue fell 25% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 8%. EBITDA rose 62% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹3.05 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹4.91 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -44% | ||||
| Net Profit Margin | -70.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Genepath Diagnostics India Private Limited, buy the company report.
Board of directors of Genepath Diagnostics India Private Limited
Genepath Diagnostics India has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nikhil Dileep Phadke Also directs: Phadke Hospital LLP, Causeway Healthcare Private Limited, Save Pune Traffic Movement and 1 more | Director | 29 Jan 2019 | 7 Years 9 Months | Current |
| Christopher Leigh Kolenaty Also directs: Causeway Healthcare Private Limited, Snow Leopard Lever Boost LLP, Snow Leopard Infrastructure-1 LLP and 5 more | Director | 11 Apr 2019 | 7 Years 6 Months | Current |
Auditor
Genepath Diagnostics India Private Limited is audited by B S & Co LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| B S & Co LLP | FY 2022 | W100072 |
Shareholding
The shareholding of Genepath Diagnostics India Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Genepath Diagnostics India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Genepath Diagnostics India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Genepath Diagnostics India Private Limited has 1 MSME Form 1 return on record for the period ending Sep 2020, listing 3 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Nirav Biosolutions Private Limited |
To see the full MSME payment records of Genepath Diagnostics India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Genepath Diagnostics India Private Limited has a workforce of 52 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
52
Active EPFO establishments
1
Employee growth
-13.33%
GST
Genepath Diagnostics India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCG6623M1Z7 | Maharashtra | Active | 01 Mar 2019 |
To see the full GST registrations and return filing status of Genepath Diagnostics India Private Limited, buy the company report.
Recent activity
Genepath Diagnostics India Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Christopher Leigh Kolenaty ceased to be Additional Director on 31 Dec 2020.
AGM
Genepath Diagnostics India Private Limited last Annual general meeting of members was held on 24 Sep 2025 as per latest MCA records.
Filing
Genepath Diagnostics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Ceased
Christopher Leigh Kolenaty ceased to be Additional Director.
Appointed
Christopher Leigh Kolenaty was appointed as Director.
Ceased
Sangeeta Dileep Phadke ceased to be Director.
Appointed
Nikhil Dileep Phadke was appointed as Director.
Incorporation
29 Jan 2019
Genepath Diagnostics India Private Limited was registered on 29 Jan 2019 with Roc Pune & aged 7 years 9 months as per MCA records.
News
Frequently asked questions
Genepath Diagnostics India is an active private limited company based in Pune, Maharashtra, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 29 January 2019 (7+ years old) and is registered under CIN U74999PN2019PTC181759.
Genepath Diagnostics India has 2 current directors:
- Nikhil Dileep Phadke - Director
- Christopher Leigh Kolenaty - Director
The latest financial statements of Genepath Diagnostics India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 24 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Genepath Diagnostics India is 27AAHCG6623M1Z7, registered in Maharashtra.
The CIN (Corporate Identification Number) of Genepath Diagnostics India is U74999PN2019PTC181759. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genepath Diagnostics India was incorporated on 29 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Pune.
Christopher Leigh Kolenaty ceased to be Additional Director on 31 Dec 2020. Christopher Leigh Kolenaty was appointed as Director on 11 Apr 2019. Sangeeta Dileep Phadke ceased to be Director on 11 Apr 2019. Genepath Diagnostics India has 4 board changes on record in total.
Yes, Genepath Diagnostics India is registered as a small enterprise under Udyam registration (number: UDYAM-MH-26-0262203).
Genepath Diagnostics India has 1 MSME Form 1 return on record for the period ending Sep 2020, listing 3 overdue payments to 1 micro and small supplier. The latest return was filed on 13 Mar 2021.
Genepath Diagnostics India can be reached through the website genepathdx.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Genepath Diagnostics India is at 4th Floor Above Phadke Hospital 1260B J M Road Shivajinagar, Pune, Maharashtra, India – 411004.